You are here: Industry Insights > Sanofi

News List

Sanofi invests 50 million euros in Jeito Capital expresspharma
November 16, 2020
The investment will be deployed by Jeito’s team, in line with its investment criteria, to support French and European healthcare entrepreneurs.
Sanofi to buy Kiadis pharmatimes
November 04, 2020
Sanofi has entered into a deal to buy Kiadis, a clinical-stage biopharmaceutical company developing innovative ‘off the shelf’ natural killer (NK) cell based medicines for the treatment of life-threatening diseases.
Sanofi teams up with MSD to test new oncology treatment pharmatimes
October 30, 2020
Sanofi has entered an agreement with MSD – known as Merck & Co in the US – to collaborate on a phase II trial evaluating its investigational candidate THOR-707 alongside MSD’s immunotherapy Keytruda.
Sanofi, GSK to Support COVAX with 200 Million Doses of COVID-19 Vaccine americanpharmaceuticalreview
October 29, 2020
Sanofi and GSK have signed a Statement of Intent with Gavi, the legal administrator of the COVAX Facility, a global risk-sharing mechanism for pooled procurement and equitable distribution of eventual COVID-19 vaccines.
Sanofi, Parkinson's Foundation to Advance Availability of Genetic Testing for Parkinson's americanpharmaceuticalreview
October 23, 2020
Sanofi and the Parkinson's Foundation announced a new research collaboration to advance the availability of genetic testing and counseling for people living with Parkinson's disease in the U.S. Over the next two years, Sanofi will provide $1 million ...
Sanofi's Sarclisa bags NICE recommendation pharmatimes
October 19, 2020
French pharma Sanofi’s Sarclisa has been granted a positive recommendation from the National Institute for Health and Care (NICE) for patients with multiple myeloma.
Sanofi and Translate Bio mRNA COVID-19 vaccine candidate induced high antibody levels in preclinical studies worldpharmanews
October 16, 2020
Sanofi Pasteur, the vaccines global business unit of Sanofi, and Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company, announced the preclinical results for MRT5500, a mRNA-based vaccine candidate against SARS-CoV-2, the virus that...
Vaibhav Karandikar is the new Chief Financial Officer of Sanofi India expresspharma
October 15, 2020
Before joining Sanofi 13 years ago, Karandikar has worked with Sandoz India, Tata Power and Hindustan Ciba Geigy.
Sanofi’s Dupixent reduces severe asthma attacks in children pharmatimes
October 15, 2020
Sanofi’s biologic therapy Dupixent (dupilumab) hit the mark in recently published data from a pivotal phase III trial.
Sanofi India appoints Vaibhav Karandikar as CFO expresspharma
October 12, 2020
The board of directors of Sanofi India at its meeting held on October 5, 2020 approved appointment of Vaibhav Karandikar as Chief Financial Officer and Key Managerial Personnel with effect from October 6, 2020.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 43 44 Next page